Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fautrel

Showing results (141-150 of 371) with videos related to

Pageof 38
Sort By:
Joint Bone Spine|September 4, 2025
Health care practices in symptomatic knee and hip osteoarthritis patients in primary care: the KHOALA cohortAnne-Christine Rat, Jean-Hugues Salmon, Willy Ngueyon Sime, et al.
The Journal of Rheumatology|May 3, 2011
Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohortCécile Gaujoux-Viala, Anne-Christine Rat, Francis Guillemin, et al.
Rheumatology (Oxford, England)|April 11, 2018
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countriesErnest Choy, Roberto Caporali, Ricardo Xavier, et al.
Arthritis and Rheumatism|September 10, 2011
Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activityViolaine Foltz, Frédérique Gandjbakhch, Fabien Etchepare, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE studyRené-Marc Flipo, Florence Tubach, Philippe Goupille, et al.
RMD Open|June 23, 2022
Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare databaseRaphaele Seror, Alexandre Lafourcade, Yann De Rycke, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 6, 2022
Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical TrialsBruno Fautrel, Jianmin Wu, Duzhe Wang, et al.
Rheumatology (Oxford, England)|May 26, 2018
Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohortBaptiste Louveau, Yann De Rycke, Alexandre Lafourcade, et al.
Joint Bone Spine|June 18, 2011
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAICécile Gaujoux-Viala, Gaël Mouterde, Athan Baillet, et al.
Clinical and Experimental Rheumatology|October 1, 2021
Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohortSamantha Rodríguez-Muguruza, Bernard Combe, Francis Guillemin, et al.
Pageof 38

Showing results (141-150 of 371) with videos related to

Sort By:
Pageof 38
Joint Bone Spine|September 4, 2025
Health care practices in symptomatic knee and hip osteoarthritis patients in primary care: the KHOALA cohortAnne-Christine Rat, Jean-Hugues Salmon, Willy Ngueyon Sime, et al.
The Journal of Rheumatology|May 3, 2011
Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohortCécile Gaujoux-Viala, Anne-Christine Rat, Francis Guillemin, et al.
Rheumatology (Oxford, England)|April 11, 2018
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countriesErnest Choy, Roberto Caporali, Ricardo Xavier, et al.
Arthritis and Rheumatism|September 10, 2011
Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activityViolaine Foltz, Frédérique Gandjbakhch, Fabien Etchepare, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE studyRené-Marc Flipo, Florence Tubach, Philippe Goupille, et al.
RMD Open|June 23, 2022
Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare databaseRaphaele Seror, Alexandre Lafourcade, Yann De Rycke, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 6, 2022
Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical TrialsBruno Fautrel, Jianmin Wu, Duzhe Wang, et al.
Rheumatology (Oxford, England)|May 26, 2018
Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohortBaptiste Louveau, Yann De Rycke, Alexandre Lafourcade, et al.
Joint Bone Spine|June 18, 2011
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAICécile Gaujoux-Viala, Gaël Mouterde, Athan Baillet, et al.
Clinical and Experimental Rheumatology|October 1, 2021
Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohortSamantha Rodríguez-Muguruza, Bernard Combe, Francis Guillemin, et al.
Pageof 38